Successful management of delirium with dexmedetomidine in a patient with haloperidol-induced neuroleptic malignant syndrome: A case report
Journal
World journal of clinical cases
Journal Volume
10
Journal Issue
2
Pages
625
Date Issued
2022-01-14
Author(s)
Abstract
We report a case of lorazepam-induced agitated delirium treated with haloperidol, which in turn triggered the onset of neuroleptic malignant syndrome (NMS). The latter condition, a medical emergency, was effectively treated with medical treatment and dexmedetomidine, a versatile and highly selective short-acting alpha-2 adrenergic agonist with sedative-hypnotic and anxiolytic effects.
Subjects
Alpha-2 adrenergic agonists; Case report; Delirium; Dexmedetomidine; Haloperidol; Neuroleptic malignant syndrome
Publisher
BAISHIDENG PUBLISHING GROUP INC